NRX Pharmaceuticals, Inc. Equity Method Investments
NRX Pharmaceuticals, Inc. (NRXP) had Equity Method Investments of $402.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:EquityMethodInvestments · last filed 2026-08-14
- 2026-06-30: Equity Method Investments $402.00K.
- 2026-03-31: Equity Method Investments $399.00K.
- 2025-12-31: Equity Method Investments $397.00K.
- 2024-12-31: Equity Method Investments $0.00.
| Period end | Equity Method Investments |
|---|---|
| 2026-06-30 | $402.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $399.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $397.00K 10-Q · filed 2026-08-14 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |